Lightwave Logic Inc (LWLG)

[Lewrock]

Panda was careful not to lie so there is almost no information in his article. For instance,

“Regarding that May 2023 commercial agreement, there were no revenues from it in Q2 and Q3”

He doesn’t acknowledge that revenues did begin in Q4 (October) because that is when the licensee ordered their first batch of Perkinamine. No credible author would leave out 99% of all of the extremely bullish and relevant information.

The only thing he acknowledged was the possibility of a short squeeze. If that does happen, he can claim he was right. (It actually could happen if Lebby’s December 4th prognostication is announced properly).